文献速递慢阻肺呼吸道感染

急性与慢性呼吸道定植及感染在慢阻肺发病机制中的作用

The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.
PubMed 文献 · Respirology · 2017-03-25

该综述探讨呼吸道感染在慢阻肺发病与进展中的作用,指出流感嗜血杆菌、卡他莫拉菌和肺炎链球菌与慢阻肺急性加重(AECOPD)强相关,但稳定期定植的临床意义尚不明确;稳定期定植患者的免疫反应与AECOPD相当,提示慢性定植通过持续有害免疫反应参与发病;分子诊断与宏基因组学进展揭示与慢阻肺状态相关的微生物群变化,肺微生物组有望成为预后标志物。

要点

  • 流感嗜血杆菌、卡他莫拉菌和肺炎链球菌与AECOPD强相关。
  • 稳定期定植患者免疫反应与AECOPD相当,提示慢性定植参与发病。
  • 肺微生物组特征有望预测慢阻肺结局或感染易感性。

核心结论

  • 慢性呼吸道定植可能通过持续有害免疫反应参与慢阻肺发病机制。
  • 肺微生物组表征有望揭示慢阻肺预后标志物并促进患者分层管理。

研究设计与样本

  • 综述,聚焦急性与慢性呼吸道定植及感染在慢阻肺发病机制中的作用。

主要发现

  • 流感嗜血杆菌、卡他莫拉菌和肺炎链球菌与AECOPD强相关。
  • 稳定期定植慢阻肺患者的免疫反应与AECOPD检测到的相当。
  • 分子诊断与宏基因组学揭示与慢阻肺疾病状态相关的微生物群变化。

临床怎么用

  • 关注稳定期呼吸道定植的免疫效应,而不仅限于急性加重期。
  • 利用分子诊断与宏基因组学评估肺微生物组以辅助预后判断。

局限性

  • 稳定期慢阻肺患者中病原体定植的临床相关性尚不明确。
  • 微生物-宿主相互作用机制尚未完全阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

COPD is a major global concern, increasingly so in the context of ageing populations. The role of infections in disease pathogenesis and progression is known to be important, yet the mechanisms involved remain to be fully elucidated. While COPD pathogens such as Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae are strongly associated with acute exacerbations of COPD (AECOPD), the clinical relevance of these pathogens in stable COPD patients remains unclear. Immune responses in stable and colonized COPD patients are comparable to those detected in AECOPD, supporting a role for chronic colonization in COPD pathogenesis through perpetuation of deleterious immune responses. Advances in molecular diagnostics and metagenomics now allow the assessment of microbe-COPD interactions with unprecedented personalization and precision, revealing changes in microbiota associated with the COPD disease state. As microbial changes associated with AECOPD, disease severity and therapeutic intervention become apparent, a renewed focus has been placed on the microbiology of COPD and the characterization of the lung microbiome in both its acute and chronic states. Characterization of bacterial, viral and fungal microbiota as part of the lung microbiome has the potential to reveal previously unrecognized prognostic markers of COPD that predict disease outcome or infection susceptibility. Addressing such knowledge gaps will ultimately lead to a more complete understanding of the microbe-host interplay in COPD. This will permit clearer distinctions between acute and chronic infections and more granular patient stratification that will enable better management of these features and of COPD.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Leung JM, Tiew PY, Mac Aogáin M, et al. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology. 2017. PMID: 28342288. doi:10.1111/resp.13032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。